Conferences

Continuing Education Conference

Logevity: The New Frontier

Friday, November 6, 2026, 8:00a-3:30p ET
Online Symposium

Longevity: The New Frontier is a virtual continuing education symposium that explores the latest evidence-based approaches to optimizing health, enhancing well-being, and supporting healthy aging through an integrative medicine lens. This timely and engaging program brings together leading experts from the Marcus Institute of Integrative Health and thought leaders from across the field to examine emerging research, clinical innovations, and practical applications in longevity medicine.

Attendees will gain insight into key topics shaping the future of longevity care, including:

  • Hormones
  • Peptides
  • GLP-1 therapies
  • Pain management
  • Lifestyle interventions
  • Other strategies designed to promote healthspan and improve quality of life

Through expert presentations and evidence-informed discussions, participants will explore how advances in preventive and personalized medicine can be translated into clinical practice to support healthy aging across diverse patient populations.

Designed with busy healthcare professionals in mind, this fully virtual live experience offers the flexibility to learn from anywhere while engaging with cutting-edge research and expert perspectives. Participants will leave with actionable knowledge and practical tools to help guide conversations and clinical decision-making related to longevity, wellness, and age-related health optimization.

Event Overview

Date:
Friday, November 6th, 2026

Time:
8:00am-3:30pm ET

Location:
Zoom Webinar

Attendance Information:

  • Live virtual
  • Discounts available for students, Jefferson staff, and faculty

Time Speaker Topic
8:00 AM   Opening Remarks
8:15 AM   Session 1
9:15 AM   Session 2
10:15 AM MORNING BREAK
10:30 AM   Session 3
11:30 AM   Session 4
12:30 PM LUNCH BREAK
1:30 PM   Session 5
2:30PM   Session 6

Accreditation Information

*CME/CEU information and accreditation details forthcoming, pending approval.